View in EDS HTML Full Text PDF Full Text

Exploring the Impact of Schizophrenia and Its Pharmacological Treatment on Health-Related Quality of Life and Treatment Preferences.

Saved in:
Bibliographic Details
Title: Exploring the Impact of Schizophrenia and Its Pharmacological Treatment on Health-Related Quality of Life and Treatment Preferences.
Authors: Arango C; Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, CIBERSAM, IiSGM, Universidad Complutense, School of Medicine, Madrid, Spain., Baeza I; Department of Child and Adolescent Psychiatry and Psychology, 2021SGR01319, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Spain; Fundació de Recerca Clínic Barcelona-Institut d´Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM; Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain., García-Rizo C; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona Spain; Centro de Investigación Biomédica en red de salud Mental (CIBERSAM), Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Medicine Department, Barcelona, Spain., Crespo-Facorro B; Hospital Universitario Virgen del Rocío, Av. Manuel Siurot, s/n, 41013, Sevilla, Spain; Centro Investigación Biomédica en Red Salud Mental, CIBERSAM, Madrid, Spain; Instituto de Biomedicina de Sevilla (IBiS), HUVR/CSIC/Universidad de Sevilla, Seville, Spain; Department of Psychiatry, Universidad de Sevilla, Seville, Spain., Lahera G; Faculty of Medicine and Health Sciences, University of Alcalá, Madrid, Spain; CIBERSAM, Ramón y Cajal Institute of Sanitary Research (IRYCIS), Madrid, Spain; Principe de Asturias University Hospital, Alcalá, Spain., Vieta E; Department of Psychiatry and Psychology, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain., Becker F; Putnam Associates, Fitzrovia, London, England., Dwyer G; Putnam Associates, Fitzrovia, London, England., Bourke S; Putnam Associates, Fitzrovia, London, England., Gibson AEJ; Putnam Associates, Fitzrovia, London, England., Gabarda-Inat I; Angelini Pharma España S.L.U. Global Medical Department, Barcelona, Spain., Alvarez-Baron E; Angelini Pharma España S.L.U. Global Medical Department, Barcelona, Spain.
Source: Patient preference and adherence [Patient Prefer Adherence] 2025 Aug 27; Vol. 19, pp. 2647-2661. Date of Electronic Publication: 2025 Aug 27 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475748 Publication Model: eCollection Cited Medium: Print ISSN: 1177-889X (Print) Linking ISSN: 1177889X NLM ISO Abbreviation: Patient Prefer Adherence Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40901561
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Exploring the Impact of Schizophrenia and Its Pharmacological Treatment on Health-Related Quality of Life and Treatment Preferences.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Arango+C%22">Arango C</searchLink>; Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, CIBERSAM, IiSGM, Universidad Complutense, School of Medicine, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Baeza+I%22">Baeza I</searchLink>; Department of Child and Adolescent Psychiatry and Psychology, 2021SGR01319, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Spain; Fundació de Recerca Clínic Barcelona-Institut d´Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM; Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22García-Rizo+C%22">García-Rizo C</searchLink>; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona Spain; Centro de Investigación Biomédica en red de salud Mental (CIBERSAM), Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Medicine Department, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Crespo-Facorro+B%22">Crespo-Facorro B</searchLink>; Hospital Universitario Virgen del Rocío, Av. Manuel Siurot, s/n, 41013, Sevilla, Spain; Centro Investigación Biomédica en Red Salud Mental, CIBERSAM, Madrid, Spain; Instituto de Biomedicina de Sevilla (IBiS), HUVR/CSIC/Universidad de Sevilla, Seville, Spain; Department of Psychiatry, Universidad de Sevilla, Seville, Spain.<br /><searchLink fieldCode="AU" term="%22Lahera+G%22">Lahera G</searchLink>; Faculty of Medicine and Health Sciences, University of Alcalá, Madrid, Spain; CIBERSAM, Ramón y Cajal Institute of Sanitary Research (IRYCIS), Madrid, Spain; Principe de Asturias University Hospital, Alcalá, Spain.<br /><searchLink fieldCode="AU" term="%22Vieta+E%22">Vieta E</searchLink>; Department of Psychiatry and Psychology, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Becker+F%22">Becker F</searchLink>; Putnam Associates, Fitzrovia, London, England.<br /><searchLink fieldCode="AU" term="%22Dwyer+G%22">Dwyer G</searchLink>; Putnam Associates, Fitzrovia, London, England.<br /><searchLink fieldCode="AU" term="%22Bourke+S%22">Bourke S</searchLink>; Putnam Associates, Fitzrovia, London, England.<br /><searchLink fieldCode="AU" term="%22Gibson+AEJ%22">Gibson AEJ</searchLink>; Putnam Associates, Fitzrovia, London, England.<br /><searchLink fieldCode="AU" term="%22Gabarda-Inat+I%22">Gabarda-Inat I</searchLink>; Angelini Pharma España S.L.U. Global Medical Department, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Alvarez-Baron+E%22">Alvarez-Baron E</searchLink>; Angelini Pharma España S.L.U. Global Medical Department, Barcelona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101475748%22">Patient preference and adherence</searchLink> [Patient Prefer Adherence] 2025 Aug 27; Vol. 19, pp. 2647-2661. <i>Date of Electronic Publication: </i>2025 Aug 27 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Press+Limited%22">Dove Press Limited </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101475748 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1177-889X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221177889X%22">1177889X </searchLink><i>NLM ISO Abbreviation: </i>Patient Prefer Adherence <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40901561
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/PPA.S494721
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2647
    Titles:
      – TitleFull: Exploring the Impact of Schizophrenia and Its Pharmacological Treatment on Health-Related Quality of Life and Treatment Preferences.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Arango C
      – PersonEntity:
          Name:
            NameFull: Baeza I
      – PersonEntity:
          Name:
            NameFull: García-Rizo C
      – PersonEntity:
          Name:
            NameFull: Crespo-Facorro B
      – PersonEntity:
          Name:
            NameFull: Lahera G
      – PersonEntity:
          Name:
            NameFull: Vieta E
      – PersonEntity:
          Name:
            NameFull: Becker F
      – PersonEntity:
          Name:
            NameFull: Dwyer G
      – PersonEntity:
          Name:
            NameFull: Bourke S
      – PersonEntity:
          Name:
            NameFull: Gibson AEJ
      – PersonEntity:
          Name:
            NameFull: Gabarda-Inat I
      – PersonEntity:
          Name:
            NameFull: Alvarez-Baron E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 08
              Text: 2025 Aug 27
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1177-889X
          Numbering:
            – Type: volume
              Value: 19
          Titles:
            – TitleFull: Patient preference and adherence
              Type: main
ResultId 1